Mature overall survival results of the INAVO120 trial were presented in a press conference for the American Society of ...

AstraZeneca is putting the pedal to the metal to drive up early detection of prostate cancer. | AstraZeneca is putting the ...

Successful trial results in the next few years could save thousands of lives and generate billions in new annual revenue for ...

Kicking off this week in Chicago, this year’s American Association for Cancer Research conference will feature presentations ...

The collaboration aims to integrate these algorithms into routine eye examinations, facilitating the diagnosis of CKD.

In summary, although deal volume is down, there are fewer but larger deal sizes. Life sciences companies that can demonstrate ...

Roche's Itovebi was the first PI3K inhibitor to get approved as a first-line treatment for breast cancer last year – and new ...

A full house was in Croke Park on Wednesday, May 14 for the inaugural All-Island Cancer Summit, which marked its presence ...

Weekend, the spotlight won't only be on speed?it'll be on saving lives. ZERO Prostate Cancer (ZERO), the nation's leading advocacy and support organization for prostate cancer, is proud to announce ...

Use precise geolocation data. Actively scan device characteristics for identification. Store and/or access information on a device. Personalised advertising and content, advertising and content ...

Geoffrey Porges, a longtime biotech analyst and well-known Wall Street figure, stepped down as CFO of the New York biotech ...

In addition, AstraZeneca, Daiichi Sankyo, and the pan-Canadian Pharmaceutical Alliance (pCPA) have signed a Letter of Intent under the Temporary Access Process (pTAP). Together with the TLR, this ...